UBS Group AG - VOR BIOPHARMA INC ownership

VOR BIOPHARMA INC's ticker is VOR and the CUSIP is 929033108. A total of 50 filers reported holding VOR BIOPHARMA INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
UBS Group AG ownership history of VOR BIOPHARMA INC
ValueSharesWeighting
Q3 2023$34,683
+9.8%
16,360
+60.1%
0.00%
Q2 2023$31,574
+16.2%
10,218
+150.0%
0.00%
Q4 2022$27,179
+579.5%
4,087
+372.5%
0.00%
Q2 2022$4,000
-95.2%
865
-87.9%
0.00%
Q4 2021$83,000
+8200.0%
7,167
+19270.3%
0.00%
Q3 2021$1,000
-98.9%
37
-99.3%
0.00%
Q2 2021$95,000
-69.0%
5,118
-27.8%
0.00%
Q1 2021$306,0007,0930.00%
Other shareholders
VOR BIOPHARMA INC shareholders Q2 2022
NameSharesValueWeighting ↓
5AM Venture Management, LLC 6,361,723$73,923,00013.88%
RA Capital Management 11,120,973$129,226,0002.28%
Paradigm Biocapital Advisors LP 629,342$7,313,0002.09%
OUP Management Co., LLC 374,714$4,354,0001.96%
JOHNSON & JOHNSON 1,074,658$12,488,0001.42%
Sarissa Capital Management LP 707,010$8,215,0000.71%
Woodline Partners LP 1,111,123$12,911,0000.18%
Artal Group S.A. 550,000$6,391,0000.17%
Orbimed Advisors 833,333$9,683,0000.12%
Laurion Capital Management LP 857,308$9,962,0000.10%
View complete list of VOR BIOPHARMA INC shareholders